<?xml version='1.0'?>
<!DOCTYPE art SYSTEM 'http://www.biomedcentral.com/xml/article.dtd'>
<art>
   <ui>ar637</ui>
   <ji>ARJ</ji>
   <fm>
      <dochead>Meeting abstract</dochead>
      <bibl>
         <title>
            <p>High-affinity antibodies against &#946;<sub>2</sub>-glycoprotein I</p>
         </title>
         <aug>
            <au id="A1">
               <snm>Cucnik</snm>
               <fnm>S</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A2">
               <snm>Kveder</snm>
               <fnm>T</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A3">
               <snm>Ambrozic</snm>
               <fnm>A</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A4">
               <snm>Borut</snm>
               <fnm>B</fnm>
               <insr iid="I1"/>
            </au>
         </aug>
         <insg>
            <ins id="I1">
               <p>Department of Rheumatology, University Medical Centre, Ljubljana, Slovenia</p>
            </ins>
         </insg>
         <source>Arthritis Res Ther</source>
         <supplement>
            <title>
               <p>23rd European Workshop for Rheumatology Research</p>
            </title>
            <sponsor>
               <note>The organizer would like to thank the following companies who have generously supported the 23rd European Workshop for Rheumatology Research: Abbott, Amgen, Aventis, Merck Sharp and Dohme, Novartis, Pharmacia, Schering-Plough, Wyeth</note>
            </sponsor>
            <note>Meeting abstracts</note>
         </supplement>
         <conference>
            <title>
               <p>23rd European Workshop for Rheumatology Research</p>
            </title>
            <location>Marseille, France</location>
            <date-range>27 February &#8211; 2 March 2003</date-range>
         </conference>
         <issn>1478-6354</issn>
         <pubdate>2003</pubdate>
         <volume>5</volume>
         <issue>Suppl 1</issue>
         <fpage>7</fpage>
         <xrefbib>
            <pubid idtype="doi">10.1186/ar637</pubid>
         </xrefbib>
      </bibl>
      <history>
         <pub>
            <date>
               <day>24</day>
               <month>2</month>
               <year>2003</year>
            </date>
         </pub>
      </history>
   </fm>
   <bdy>
      <sec>
         <st>
            <p>Background</p>
         </st>
         <p>Antibodies against &#946;<sub>2</sub>-glycoprotein I (anti-&#946;2GPI) are believed to be of low affinity and thus unable to bind to the free antigen in a solution.</p>
      </sec>
      <sec>
         <st>
            <p>Objective</p>
         </st>
         <p>The aim of our study was to determine the affinity of IgG anti-&#946;2GPI, isolated by affinity chromatography.</p>
      </sec>
      <sec>
         <st>
            <p>Methods</p>
         </st>
         <p>A &#946;2GPI affinity column was prepared by CNBr-activated agarose without spacer arms and human purified unnicked &#946;2GPI. The IgG fraction from the protein G column was applied to the column and bound antibodies were eluted with various solutions: A) 0.1 M glycine / 0.5 M NaCl / 0.1% Tween 20 pH 2.5; B) 0.1 M glycine / 4 M NaCl / 0.1% Tween 20 pH 2.5; C) 0.1 M sodium borate pH 10 and D) 25% ethylene glycol. Eluted fractions containing anti-&#946;2GPI antibodies were neutralised and analysed by ELISA using various binding buffers. The level of anti-&#946;2GPI antibodies in each sample was derived from the standard curve according to the defined dilutions of monoclonal antibodies (AUG are arbitrary units of IgG monoclonals).</p>
      </sec>
      <sec>
         <st>
            <p>Results</p>
         </st>
         <p>Increased concentrations of sodium ions in the binding solution from 0.15, 0.25, 0.50, 1.11, 2.07 and 4.0 M NaCl did not completely prevent the binding between isolated antibodies and &#946;<sub>2</sub>-GPI (79.8, 65.3, 36.1, 19.9, 12.0 and 8.1 AUG, respectively).</p>
      </sec>
      <sec>
         <st>
            <p>Conclusion</p>
         </st>
         <p>In contrast to the common opinion that all anti-&#946;2GPI autoantibodies are of low affinity, we clearly showed that at least one subset among them was of high affinity.</p>
      </sec>
   </bdy>
</art>
